Summary
Oral and maxillofacial organoids, as three-dimensional study models of organs, have attracted increasing attention in tissue regeneration and disease modeling. However, traditional strategies for organoid construction still fail to precisely recapitulate the key characteristics of real organs, due to the difficulty in controlling the self-organization of cells in vitro. This review aims to summarize the recent progress of novel approaches to engineering oral and maxillofacial organoids. First, we introduced the necessary components and their roles in forming oral and maxillofacial organoids. Besides, we discussed cutting-edge technology in advancing the architecture and function of organoids, especially focusing on oral and maxillofacial tissue regeneration via novel strategy with designed cell-signal scaffold compounds. Finally, current limitations and future prospects of oral and maxillofacial organoids were represented to provide guidance for further disciplinary progression and clinical application to achieve organ regeneration.
Subject areas: Biological sciences, biomedical engineering, materials science, biomaterials
Graphical abstract

Biological sciences; Biomedical engineering; Materials science; Biomaterials
Introduction
The treatment and repair of oral and maxillofacial defects remain challenging since it is difficult to regenerate tissues and restore their function and aesthetics.1 Typically, current approaches to restore maxillofacial defects caused by cancer, trauma, and infection, primarily involve artificial prosthesis2 and autograft.3 However, considering the drawbacks of current ways in the morphological similarity, morbidity, and availability,4 a more eminent and biocompatible strategy is highly desirable for further optimizing the treatment of oral and maxillofacial regeneration, which is a promising alternative in clinical application.
Organoids, three-dimensional (3D) structures generated from self-organizing stem cells, including pluripotent stem cells (PSCs), adult stem cells (ASCs), and other specific cell lines, have high similarity to native organs in architectural and functional complexity.5,6 Compared with a two-dimensional (2D) cell culture system, the more sophisticated 3D organoids model can effectively simulate the structure and properties of original organs, particularly in their gene and protein expression patterns, cell-matrix interactions, and metabolic functions.7 Moreover, the self-renewable ability and accessibility of genetic manipulation of organoids made them appropriate for studying organ development and pathophysiology in vitro. Therefore, organoids have been applied in modeling organogenesis8 and developmental disorders,9 diagnosing diseases,10 and repairing defects.11
Recently, widely used organoids have been employed in the structure-complicated and disease-diverse oral and maxillofacial system, including tooth germ organoids,12 salivary gland organoids,13 oral cancer organoids,14 taste bud organoids,15 lingual epithelial organoids,16 and temporomandibular joint organoids.17 As shown in Figure 1, the development of oral and maxillofacial organoids mainly involves stem cells such as ASCs, PSCs, and the microenvironments (or niches) of different stem cells during organogenesis. With the supplement of culture components such as extracellular matrix (ECM) and molecules, ASCs and PSCs can reprogram and differentiate into different types of cells thereby forming various organoids.18 The developed organoids serve as an excellent model for treating various oral and maxillofacial diseases including oral cancer,19 teeth regeneration20 and salivary gland repair.21
Figure 1.
Components and categories of maxillofacial and oral organoids
However, the stochastic and uncertain nature of the self-organization of stem cells during organoid development in vitro gives rise to immature morphology and incomplete functions. These limitations associated with conventional oral and maxillofacial organoids should be addressed prior to their clinical applications.22 Efforts have been made to engineer organoids to ensure their morphology and functions similar to native organs. The advancements made in organoid culturing strategies could be attributed to genetic editing,23,24,25 optimizing the composition of the ECM,26,27,28 and developing new scaffold materials.29,30,31 These techniques aid in regulating cell proliferation and differentiation. Remarkable progression has been made in the bio-engineered organoids which have enhanced the therapeutic potential and clinical value of oral and maxillofacial organoids.
Therefore, in this study, we have summarized the current techniques used for oral and maxillofacial organoid development. We have also discussed the challenges associated with organoid development. First, we shed light on the conventional methodology and the fundamental components required for organoid development. In the second section, we have discussed and listed various strategies used to engineer organoids. In the third section, we focus on specific bioengineering methods and advancements in oral and maxillofacial organoid development. Finally, we have highlighted the challenges associated with organoid development and the future prospects of oral and maxillofacial organoids.
Stem cells, scaffolds, and growth factors are essential components for generating oral and maxillofacial organoids, including tooth germ organoids, salivary gland organoids, lingual epithelia organoids, taste bud organoids, oral cancer organoids, maxillofacial cartilage organoids.
Conventional organoids design
The development of organoids primarily involves the self-organization of different types of cells, which are regulated by basic signal pathways. Therefore, three factors, including cell types, supporting structure, and endogenous and exogenous signals, are fundamental requirements during the process of organoid construction. Any changes in these factors may impact organoid development and its functions.
Cells
Cells for generating organoids derive from ASCs,10 PSCs,32 and somatic cells.33 Since the restriction of somatic cells on differentiation, these somatic cells are less extensively applied in organoid construction versus stem cells, and will not be the focus here. Stem cells including PSCs and ASCs have the intrinsic capability to assemble into complex structures with the presence of suitable exogenous factors and appropriate supporting structure, due to their multipotent differentiation and self-renewal capability. In general, the behavior and fate of cells in the process of organoid formation involve proliferation, differentiation, and self-organization, which contains cell sorting and architectural rearrangement.34 Therefore, the characteristics of organoids partly rely on the starting cell type.
ASCs, known as tissue stem cells, are undifferentiated cells derived from specific tissues. Their sources and self-renewal abilities enable them to differentiate into tissue-specific cell types.35 Tissue-specific ASCs can spontaneously form corresponding organoids, which mitigate the uncertainty of cell differentiation when cultured in the microenvironment, simulating the development of actual in vivo organs. Therefore, ASC-derived organoids can be utilized to study tissue biology by efficiently imitating the homeostatic or regenerative conditions of corresponding original tissues.36 For example, dental pulp stem cells, as ASCs derived from dental pulp tissues have outstanding odontogenic ability, which can generate tooth germ organoids by simulating dental mesenchyme.37 However, the method to directly reconstruct organoids using ASCs may be hard because of their unavailable source from some special tissues such as the heart and brain.
PSCs exhibit more excellent self-renewal and multipotent differentiation capability.38 Most PSC-derived organoids are in the immature stage since the development toward mature cells needs a continuous culture period and intricate interaction with other co-culture cells.39 These procedures may be hard to control in most PSCs due to the difficulty in reconstructing embryonic developmental processes in vitro. Nevertheless, tissue-specific organoids including teeth,40 brain,41 and liver42 can still be generated if the differentiated PSCs are cultured in the suitable culture medium and supporting scaffold. Additional studies are required to standardize the procedure for developing PSC-derived organoids prior to further clinical application. Besides, this feature also allows the PSC-derived organoids to be widely used to explore cell-cell interaction, organogenesis, and developmental defects.
Although both of ASCs and PSCs retain the genetic information from their primitive cells, ASC-derived organoids tend to sustain original tissue phenotype, so in vitro culturing of ASC-derived organoids is easier compared with PSC-derived organoids. In contrast, even though the culturing conditions of PSC-derived organoids are complex and time-consuming, the superior potential for PSCs to differentiate into various types of cells enables them to generate unavailable tissues, which overcome the shortcomings of ASCs.
Culturing conditions
In vitro conditions for culturing and generating organoids should be similar to their in vivo microenvironment to regulate the behavior and fate of cells.43 These conditions are mainly composed of supporting structures in the culture system and endogenous and exogenous signals including different growth factors. Multiple strategies have been designed to create appropriate niches for the development of organoids.
Supporting structure
ECM, the basic component which contributes to the growth and adhesion of cells during organogenesis, plays an imperative role in providing 3D structural support during organoid morphogensis.44 Various natural and synthetic materials are used as scaffolds, providing structural support for organoid generation.
The scaffolds made of natural materials possess bioactive motifs such as Arg-Gly-Asp (RGD) and are used for culturing organoids since they mimic conditions similar to in vivo microenvironments, which are required for culturing stem cells. Matrigel, a natural source scaffold derived from Engelbreth-Holm-Swarm mouse sarcoma, can efficiently mimic the natural basement membrane.45 It has been widely applied in creating organoids such as intestinal,46 tooth,12 and gland47 organoids due to their excellent biocompatibility, bioactivity, and biodegradability. However, there are disadvantages to solely using natural scaffolds to advance the development of organoids. First, their insufficient mechanical stiffness limits the natural scaffolds to be extensively applied in organoid development. Further, natural scaffolds have a low resistance to changes in physical conditions such as pH and temperature. Hence, it is challenging to precisely modulate the culturing conditions in vitro and modify natural scaffolds.48
Compared with natural materials, synthetic scaffolds are characterized by their superior mechanical stiffness and better resistance to changes in physical conditions. Polyethylene glycol (PEG), poly (lactic-co-glycolic acid) (PLGA), and polyurethane (PU)-modified hydrogels have been reported as more prominent 3D scaffolds for their improved biocompatibility and mechanical properties to induce organoids.49 However, synthetic scaffolds have an uncontrolled degradation rate and lack bioactive motifs such as RGD, which restricts their use in organoid generation. Therefore, it is necessary to design techniques to modify synthetic scaffolds for organoid culture.
Apart from the scaffold, various studies have used other techniques to provide a microenvironment conducive to organoid development. Takasato et al. used an air-liquid interface method to create kidney organoids by generating a cell pellet on a thin and microporous membrane.50 The cell pellet developed into a multi-layered structure similar to the architecture of the actual kidney in vivo, despite the lack of scaffolds for support. Besides, 3D suspension culture induces the transformation of cell aggregation to organoids with spherical shape to generate cerebral,51 cerebellar,52 and optic cup organoids.53 Although some low concentrations of Matrigel have the capacity to efficiently generate polarized epithelial structures, scaffold materials are not necessary for cell embedding owing to specific and controlled self-organization in this suspension culture system.53
Various strategies and techniques are used to recapitulate in vivo microenvironments for generating and culturing organoids. On the contrary, these techniques have not yet to be optimized to promote organoid development. So, it is still necessary to make efforts to modify the scaffold and investigate a more suitable culture system.
Endogenous and exogenous signals
Organoid formation is usually regulated by endogenous and exogenous signals including growth factors and molecules, which play important roles in the self-renewal and differentiation of stem cells. All signaling molecules and factors required for the self-organization of stem cells should be present in the culture medium for the successful development of organoids. Therefore, in order to ensure proper self-organization, missing signals should be exogenously supplied.
Regarding oral and maxillofacial organoids, signal molecules such as bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) and signal pathways including Wnt/β-catenin play an important role in inducing orderly self-organization of stem cells.54 For example, epithelial cells supplemented with alternative exogenous growth factors including FGF2 and laminin-111 could form salivary gland organoids with normal secretory function, compared with those treated with epidermal growth factor (EGF).55 Besides, PSC-derived organoids were developed primarily relying on the exposure to exogenous signals at specific times. McCracken et al. treated PSCs with the bioactive molecule FGF4 to induce the formation of posterior foregut spheroids. Exogenous signaling molecules such as EGF and retinoic acid were added after 3 days of culturing PSCs to differentiate posterior foregut spheroids into gastric antrum organoids.38 On the contrary, few organoids’ derivations only depend on endogenous signals. Eiraku et al. reported that mouse PSCs were cultured in a serum-free medium with a low concentration of growth factors which promoted the generation of the neuroepithelium and subsequently developed into optic cup organoids without additional exogenous signals.53 Hence, for meeting the need for spatial and temporal cues of self-organization of organoids, studies should focus on exploring tissue-specific developmental mechanisms to determine the exact exogenous factors to be applied.
Even though these factors are necessary for regulating the differentiation and organization of stem cells, cell-autonomous self-organization, as the critical part of organoids generation, remains difficult to manage.8 Therefore, approaches to bioengineering organoids have attracted increasing attention in order to pursue well-organized organoids, and the specific strategies developed in recent years are described as follows.
Methods for engineering organoids
Various strategies for engineering organoids include advancing the biochemical and biophysical properties of scaffolds, improving the self-organization of stem cells, and optimizing the components of the culture niches. The aim of engineering organoids is to narrow the gaps between in vitro and in vivo model systems and recapitulate the important characteristics of actual organs. The generation of 3D organoids involves the self-renewal and differentiation of cells and the process of self-organization.56 These behaviors are mainly controlled by the components in the niches. Therefore, in order to create a spatially and temporally coordinated environment thereby realizing precise self-organization to form organoids, tremendous efforts have been made to bioengineer the cells and culturing conditions used to generate organoids (Figure 2).
Figure 2.
Methods to engineer organoids
Engineering the cell
Organoids are composed of different cell populations arranged in 3D structures. Therefore, to improve the organoids’ robustness, promote cell aggregation, and shorten the incubation period, it is necessary to develop strategies that can modify the cells and change their inherent characteristics including advancing cell surface and genome.
Engineering cell surface
The shape and size of the starting cell aggregation are significant determinants for the successful formation of organoids, which can be achieved via modifying the cell surface.57 Appropriate cell aggregation necessary for differentiation can be achieved via modifying the cell membrane to improve cell-cell adhesion. Several proteins,58 peptides,59 nanoparticles,60 and bio-orthogonal chemical species61 have been applied as functional molecules in the engineering cell membrane. Rogozhnikov et al. developed oxyamine and ketone moieties-loaded liposomes to deliver chemical functionality to the cardiac cell surface. This newly developed liposome enabled the modified cardiac cells to aggregate and arrange among different cell types to form 3D structures without any scaffolds.61 Fayol et al. reported that combined cell membrane with magnetic nanoparticles and utilized external magnetic fields to manipulate cell aggregation and rearrangement thereby forming cartilage tissues.62 Besides, the program of cell-cell adhesion could be changed and modified by binding the synthetic 3D DNA fragments into the cell surfaces.63
Genetic engineering
Apart from modifying cell surface, heritable genome editing is another effective approach for constructing more sophisticated organoids by controlling the fate and behavior of cells.64 Various studies have successfully used genetic engineering to edit genomes for altering stem cell differentiation and self-organization capability, as well as for the treatment of several genetic diseases.
The inherent response of cells generating organoids can be modified with the application of targeted gene editing technology, Clustered Regularly Interspaced Short Palindromic Repeats-associated 9 system (CRISPR-Cas9). The modified genes trigger the expression of some substances beneficial for cell terminal differentiation and promote organoids maturation. Velazquez et al. used a targeted CRISPR-Cas9-based technique for the transcriptional activation of an enzyme superfamily to reprogram a tissue-regulated network and promote PSC-derived organoid maturation.65 This gene modification was able to reprogram a tissue-regulated network and improve the cell maturation in PSC-derived organoids. However, the use of targeted genetic editing tools to control the self-organization of organoids is restricted by our limited understanding of cell behavior and regulatory networks. Further efforts to study how to precisely control the development of organoids via gene editing remain important.
Besides, gene editing technology can also be employed in the treatment of single gene mutation-induced diseases and explore different signals function in disease models. For example, CRISPR-Cas9 was used to correct the mutation in the retinitis pigmentosa GTPase regulator gene, which could effectively repair photoreceptor structure and restore the electrophysiological properties in retinal organoids.66 The expression of the adenomatous polyposis coli was knockdown by gene editing technology in Barrett epithelial organoids to explore the role of WNT signal pathway in the neoplastic transformation of Barrett epithelial cells. The result confirmed that the successful activation of the WNT signal pathway could induce neoplastic phenotype.67
Engineering the culturing conditions
Although cell aggregation is required for organoid formation, the behavior of cells is highly dependent on the culturing conditions which influence the spatiotemporal self-organization of organoids.68 In order to engineer components of the culture conditions, various state-of-the-art approaches are applied to modify the components and structure of the scaffolds. These will allow researchers to precisely control cell proliferation and differentiation for its application.69,70,71
Engineering components of scaffolds
Conventional scaffolds such as animals-derived Matrigel are used in organoid generation with limited applications due to the risk of immunogenicity. Besides, their composition is heterogeneous, which made it difficult to customize and design organoids-based experiments.72,73,74 Therefore, a number of polymer-based synthetic hydrogels such as PLGA75 and PEG-based76 hydrogels have been developed to produce designer ECM and customize niche structures. Several nanoparticles such as silica nanoparticles,77 metal, and metal oxide nanoparticles78 have been incorporated to improve mechanical stiffness and strength and enhance the magnetic property for engineering cell niches in vitro. However, the above-mentioned synthetic hydrogels cannot control and manipulate the self-organization of stem cells, which only solve fundamental problems during the culture microenvironments. Hence, the purpose of engineering components of scaffolds is to optimize the components of niches and promote the aggregation of stem cells in scaffolds.
In recent years, various approaches to emulating in vivo microenvironments by modifying the developed hydrogels have drawn increasing attention. In order to supply more exogenous signals to facilitate the self-organization of stem cells, polymers-based synthetic hydrogels are decorated with different types of bioactive molecules. PEG-based hydrogels modified with RGD peptides are developed to support the expansion and differentiation of intestinal stem cells. The susceptibility of soft RGD-functionalized synthetic hydrogels toward matrix metalloproteinases renders them more physiological by degradation over time to generate intestinal organoids.79 Besides, compared with natural basement membrane extract, the synthetic fibrin-based hydrogels exhibited similar physical characterization to support stem cells as a 3D scaffold. For instance, the laminin-111-functionalized fibrin-based hydrogels possessed more robust properties to form and expand intestinal organoids since the laminin contained the necessary chemical signals for cell self-organization.80
Growth factors, which are sequestered or immobilized in ECM macromolecules in vivo, can also be immobilized and delivered by scaffolds instead of diffusible in a culture medium. Compared with free diffusible growth factors, hydrogel-delivered growth factors possess a prolonged and stable presentation due to the prevention of enzymatic growth factor degradation. Heparin, as an anionic polymer, can make electrostatic interactions with different kinds of growth factors and protect them from losing bioactivity.81 Zieris et al. created heparin-functionalized PEG hydrogels to immobilize the fibroblast growth factor and vascular endothelial growth factor and regulate cell microenvironment thereby controlling the proliferation, growth, and differentiation of endothelial cells.82 Wylie et al. used orthogonal chemistry of peptide binding pairs to incorporate and fixed stem cell differentiation factors and ciliary neurotrophic factor to the different locations of agarose hydrogels. This chemical scaffold had the capacity to realize spatially controlled organoids development via regulating cell growth and differentiation.83
Engineering structure of scaffolds
Given the present deficiency of mechanical stiffness and morphology of natural scaffold materials, the construction of organoids with designed structures remains difficult. To circumvent this limitation, a novel type of scaffold called hybrid scaffolds was designed. Hybrid scaffolds, which are made of two or more scaffolds, contain natural and synthetic scaffolds, thus combining the advantages of both systems, such as enhanced biocompatibility and ease of modification.84 Therefore, hybrid scaffolds have bilayers and possess superior mechanical and biological properties. Using suitable growth factors and cells, these hybrid scaffolds can promote the aggregation and differentiation of stem cells.76 Recently, hybrid scaffolds produced by 3D printing technology have been utilized to engineer organoids since they can induce stem cell aggregation with predefined shapes. Li et al. printed tubular composite scaffolds with defined shapes that were capable of guiding the growth, proliferation, and differentiation of stem cells to generate bile duct organoids.85 Superparamagnetic iron oxide nanoparticles loaded-gelatin methacryloyl hydrogel was fabricated and covered the above-mentioned printed scaffolds to ensure the biocompatibility and stiffness of hybrid scaffolds for the requirement of organoid formation. Besides 3D printing, laser cutting is a material reduction process that can provide artificial boundaries to the scaffold, thereby allowing the formation of morphologically controlled organoids. Nikolaev et al. used a laser-shaped metric to form intestinal organoids to predefined tubular architecture, a crypt-villus-like patterning. More importantly, the external pumping system continuously removes the dead cells generated over time, which extended the lifespan of cells in organoids and enabled the interactions between tubes and niches. The crypt and villus regions control the growth and self-organization of stem cells, thus indicating that scaffold geometry can provide morphogenic cues required for organoid development.86
Engineering organism-level environments
Organogenesis and disease progression involve more than one specific organ and requires interaction with other cells, tissues, and organs. Therefore, methods to engineer organism-level environments are important during the process of organoid formation and application for tissue regeneration. Vascularization of organoids and mimicking organism-level interaction via microfluidic devices can be realized by advancing organism-level context.
Vascularization
Organoid maturation is limited by the lack of functional vascularization, which fails to meet the increased metabolic demand of the culturing organoids, thus causing necrosis in the core of organoids. Hence, various methods to form functional vascular attract more attention in order to promote organoid maturation. The achievements mainly focus on developing pre-vascularizing organoids and functional capillary beds for perfusable organoid platforms.
In recent years, several researchers have reported that seeding endothelial cells with organoids can form vasculature. Rossen et al. co-cultured endothelial cells with mesenchymal stem cells to generate blood-vessel organoids with controllable size and structure by sacrificial hydrogels technology.87 In addition to endothelial cells, mesodermal progenitor cells were also confirmed to promote organoid vascularization when co-cultured stem cells, since the differentiation of mesoderm-derived angioblasts initiated the development of the vascular system.88 Besides, mechanical factors such as flow and shear forces, which affected tissue homeostasis and morphogenesis thereby promoting organoid vascularization, could also be adjusted by microfabricated devices.89 For instance, the maturation of endothelial cells, which contributed to the formation of a vascular network, could be triggered by blood-flow-induced shear stresses. Homan et al. employed the controllable fluid flow in the microfluidic device to advance the maturation of kidney organoids with vascular networks by the formation of perfusable lumens.90
The interaction between internal vasculature and external functional vessels in ECM is the key to forming integrated perfusion structures in organoids to mimic organs in vivo. Hence, in addition to the generation of pre-vascularizing organoids, methods to develop functional capillary beds also play an important role in the vascularization of organoids and in vivo perfused vasculature.91 Chen et al. fabricated a microfluidic device with three parallel fluidic channels and implanted human umbilical vein endothelial cells (HUVECs) to fibrin gels in the middle region of the device to co-culture with human lung fibroblasts (HLFs).92 The capillary beds could be generated after 3 days because endothelial cells in gels could simulate in vivo niches to form vessels, which was confirmed by the perfusion of fluorescent beads. Besides, Nashimoto et al. confirmed the capillary beds were able to integrate with vessel-like structures in large spheroids, which were made from HLFs and HUVECs.93 Driven by factors secreted by HLFs, endothelial cells on the side walls could reach the spheroid thereby integrating vessels between capillary beds and spheroids. However, functional capillary beds have not yet established a stable connection with stem cell-derived organoids via an entire perfusion platform to provide sustained nutrient supplements for organoid construction. Therefore, more efforts remain required to form a better perfusion platform with organoids.
Engineering interactions at organism-level
The advent of microfluidic devices has created a powerful platform for mediating dynamic tissue-tissue interaction and organ-level interaction in organoids. Some advantages provided by microfabricated devices include: (1) They can dynamically simulate in vivo microenvironment by screening tissue and cellular components using biosensors.94 (2) The devices make it convenient to co-culture organoids with other cells such as endothelial cells in order to vascularize and neutralize organoids via cell-organoid interaction.95 (3) A holistic understanding of physiology and organogenesis can be achieved by recapitulating physiological interactions with multiple organoids via the microfabricated device.96 For example, Jin et al. co-cultured liver, intestinal and stomach organoids in microfluidic devices to study the crosstalk among different organoids during organogenesis.97 The flow of different culture media across the culture chambers enables communication among these three organoids. The liver organoids were incubated with the primary bile acid chenodeoxycholic acid, and the expression of the bile acid synthesis enzyme was evaluated to study the influence of interaction between liver and intestinal organoids on bile acid homeostasis. A decrease in bile acid synthesis enzyme expression was observed in liver organoids supplemented with bile acid chenodeoxycholic acid. This could be attributed to paracrine factors secreted by the intestinal organoid, which indicates the crosstalk between the liver and intestinal organoids. Despite the advancement in the development of oral and maxillofacial organoids, studies on the interactions among different oral organoids have not been reported yet. Increasing attention has been paid to exploring the crosstalk of multiple organoids for understanding the onset of diseases and organogenesis. Zhao et al. generated oral cancer organoids from patients with oral squamous cell carcinoma (OSCC) and co-cultured them with cancer-associated fibroblasts (CAF) to study the interaction between CAF and oral cancer organoids.14 The result showed that CAF secreted lactate to promote the growth of oral cancer organoids, suggesting that inhibiting lactate production by CAF could prevent the progression of oral cancer.
Compared with the limitation of traditional organoids, including central necrosis, malformation and dysfunction, different methods to engineer organoids are able to regulate self-organization to form organoids with vascularization, normal function, and morphological similar to the counterparts in vivo. Three main strategies for developing bioengineered organoids include engineering stem cells, engineering scaffolds, and engineering organ-level environments. First, stem cells can be engineered by genetic editing and cell surface engineering. Genetic editing can be performed using the CRISPR/Cas9 technique to knock out and overexpress genes, which can alter the fate and properties of stem cells. Cell surface engineering uses nanoparticles, peptides, proteins, and chemical moieties to modify cell surfaces and facilitate cell aggregation and differentiation. Second, scaffold engineering can be performed by engineering the components and the structure of the scaffolds. Growth factors and RGD peptides are incorporated in the scaffolds to recapitulate the in vivo microenvironment of their counterparts. Furthermore, 3D printing technology has been used to create a scaffold for generating organoids with specific and defined morphology. Third, the use of microfluidic devices guarantees a more sophisticated microenvironment for multi-organoids development by mimicking the interactions between different organs.
Strategies for engineering oral and maxillofacial organoids
The generation of oral and maxillofacial organoids is highly dependent on aggregation, differentiation, and self-organization of stem cells with the supplement and guidance of scaffolds and various growth factors. Current progress made in forming oral and maxillofacial organoids for hard and soft tissues has been listed as follows (Table 1).
Table 1.
Summary of various construction strategies for maxillofacial and oral organoids
| Organoids types | Cell types | Main scaffolds | Culturing niches | Advantages of current strategies | Limitations of current strategies |
|---|---|---|---|---|---|
| Tooth germ organoids | Dental mesenchymal cells; Hental epithelial cells; iPSCs; HUVECs | Collagen; GelMA; PLGA hydrogel | DMEM; FCS | Teeth with entire structure and vascularization have been formed | Difficult to maintain and control different shapes of teeth |
| Salivary gland organoids | iPSCs; Human epithelial cells | PEG hydrogel; PLGA Nanofibers-modified elastin; Mat rigel; |
BMP4; FGF7; FGF10; FGF2 | Structure-entire and function-normal salivary glands have been generated | Lack of vascularization; the size of the organoid generated was small |
| Oral cancer organoids | Cells from patients with OSCC | Matrigel; Silica fiber scaffold; Decellularized ECM | bFGF | The migratory and invasive ability of cells is similar to OSCC | The inability of organoids to precisely recapitulate the tumor microenvironment |
| Taste bud organoids | Lgr5+cells | Matrigel; Decellularized ECM | DMEM/F12 | Organoids can recapitulate the taste epithelium homeostasis | The inability of organoids to dynamically analyze taste signal transmission |
| Lingual epithelial organoids | Lingual epithelial cells | Matrigel | EGF; Noggin; R-spondin | Growing and maturating in muscular layer of tongue instead of only in epithelial layer | Lack of components that mimic in vivo niche and control self-organization to form a specific morphology |
| Maxillofacial cartilage organoids | Neural crest stem cells | No scaffolds | FGF8; Ascorbic acid | Organoids successfully express cartilage differentiation factors | Methods to regeneration maxillofacial cartilage with entire structure and stiffness still unexplored |
iPSCs, induced pluripotent stem cells; PLGA, poly(lactic-co-glycolic acid); HUVECs, human umbilical vein endothelial cells; GelMA, gelatin methacrylate; OSCC, oral squamous cell carcinoma; FGF, fibroblast growth factor ; EGF, epidermal growth factor; BMP, bone morphogenetic protein; ECM, extracellular matrix; PEG, polyethylene glycol; DMEM, dulbecco’s modified eagle medium.
Oral and maxillofacial hard tissues organoids
Tooth germ organoids
Tooth, as a complex tissue, is composed of hard tissues including enamel, dentin and cementum, and soft tissues including dental pulp. These structures are formed under the control of the epithelial-mesenchymal interactions and related signal molecules. Hence, the formation of tooth organoids is highly dependent on the spatial and temporal interactions between epithelial and mesenchymal to form the complex structure. In recent years, the generation of tooth germ organoids has raised more and more attention, which can be used to repair tissue damage and make progress in tooth regeneration (Figure 3).
Figure 3.
Schematic diagram of generation of engineered tooth germ organoids and tooth regeneration
The construction of tooth germ organoids mainly involves dental mesenchymal cells and dental epithelial cells co-culturing in collagen scaffolds and realizing self-organization with the stimulation of growth factors. In order to overcome the limited source of stem cells, PSCs were induced by feeder cells and differentiated into mesenchymal and epithelial cells. Besides, to further narrow the gap between actual tooth and tooth generated by organoids, various bioengineering scaffolds including electrospinning PLGA hydrogel, HUVECs-based GelMA hydrogel, and GelMA-based hydrogel microparticles have been utilized to advance tooth germ organoids. An entire tooth can be gained via implanting organoids into animal alveolar pockets or developing with the electrospinning PCL membrane in vitro. iPSCs, induced pluripotent stem cells; PLGA, poly(lactic-co-glycolic acid); HUVECs, human umbilical vein endothelial cells; GelMA, gelatin methacrylate; PCL, polycaprolactone.
The first evidence of tooth germ organoid formation was reported by Tsuji et al. through co-culturing dissociated embryonic tooth germ-derived dental epithelial (DE) and dental mesenchymal (DM) cells in a collagen gel.20 The developed tooth germ organoids could generate entirely bioengineered tooth after transplantation in alveolar fossa. The identical method has been used to successfully form tooth germ organoids for whole tooth regeneration in canine98 and porcine99 model. However, given that the autogenous tooth germs are source-limited and most of them are derived from third molars, the generation of anterior teeth may be impeded due to differences in genetic lineage. This prompted the use of PSCs in developing the tooth-germ organoids. Under the co-culture condition of dulbecco’s modified eagle medium (DMEM) and the guidance of mouse dental mesenchymal cells as feeder cells, the PSCs can differentiate into DM and DE cells and thereby forming tooth germ organoids.40 After transplantation in alveolar fossa, the tooth germ organoids developed into a tooth-like structure with stiffness and elastic modulus similar to the actual teeth. Numerous studies have paid attention to bio-engineering tooth germ organoids to regenerate well-structured tooth.
Several efforts and progress have been made in bio-engineering tooth germ organoids by modifying scaffolds. Nano-hydroxyapatite-contained electrospinning PLGA scaffolds were developed to study the effect of novelty-engineering scaffolds on generating tooth germ organoids and structure-distinct teeth in vitro. After seeding DM and DE cells, the fiber in the scaffolds guided the cell aggregation with planned orientation, and nano-hydroxyapatite promoted stem cell differentiation and ECM production. Although the effects of hybrid scaffolds in tooth generation have not been studied in vivo, it provides a valuable strategy to form spatially controlled tooth germ organoids.100
Gelatin methacrylate (GelMA)-based hydrogel, a photo-crosslinking hydrogel with outstanding porosity, degradation rates, and suitable stiffness has been applied in organoid development, compared with polymer-based hydrogels. The RGD sequence contained in GelMA, a natural cell-binding motif, also contributes to cell adhesion and matrix metalloproteinase secretion. This bioactive motif plays a significant role in natural ECM structure and organogenesis.101 Nevertheless, the teeth formed in GelMA hydrogels were small and diffused in the pores of scaffolds. So, HUVECs-loaded GelMA hydrogels were fabricated. Compared with GelMA hydrogels, HUVEC-encapsulated hydrogels enabled DE and DM cells to form tooth germs with predictable sizes and shapes and promote the functional vascularization of tooth germ organoids.102 To further improve this model, various modifications were made to the GelMA scaffolds, like optimizing cell density, cell culture duration, and culture medium to achieve a bioengineered tooth bud.103 However, the distinctive enamel and dentin structure remain unavailable, which means the GelMA method still requires more progression and modification. Therefore, in order to further improve this model, Bektas et al. fabricated GelMA-derived hydrogel microparticles to provide superior surface area for cell attachment and cell-cell interaction, which were beneficial for self-organization. The human dental pulp stem cells and porcine dental epithelial cells were seeded into the engineering scaffold and co-cultured to form tooth germ organoids in vitro.104
Moreover, Zhang et al. fabricated decellularized tooth bud scaffold which retained more components and architecture of natural ECM. After the reseeding of DE cells, DM cells, and HUVECs, the newly developed tooth germ organoids were able to generate bio-engineered entire teeth with specific sizes and shapes. The bioengineered teeth contained correct enamel, pulp, dentin, and tooth roots under the guidance of decellularized scaffold.12
In addition to different approaches to modifying scaffolds, the culture microenvironment also plays a crucial role in the development of organoids. Eap et al. created a polycaprolactone (PCL) membrane by electrospinning and functionalized it with various growth factors to closely mimic in vivo microenvironment of the actual organ. The tooth-germ organoids were coated with this newly developed membrane, which secreted appropriate signals and simulated the microenvironment during organogenesis to generate a vascularized tooth both in vitro and in vivo.105
In conclusion, the above-mentioned progress represents the current advanced methods to perfect the whole structure and function of teeth generated by tooth germ organoids. Although the application of PSCs may mitigate the problem in a limited number of embryonic tooth cells, it is necessary to explore more efficient and effective approaches to bio-engineer niches, which will contribute to the generation of the entire structures of teeth.
Oral and maxillofacial soft tissues organoids
Salivary gland organoids
The development of salivary glands is dependent on epithelium and mesenchyme interaction. The key to structuring the salivary gland organoids with the secretary function is to mimic the microenvironment of organogenesis, particularly the endogenous and exogenous signals.106 Compared with other oral and maxillofacial organoids, research related to the bio-engineered salivary gland organoids is relatively more sophisticated. Thus, numerous efforts have been made to accelerate the pace of clinical application (Figure 4).
Figure 4.
Schematic diagram of generation of engineered salivary gland organoids
(A) Stem cells source to generate salivary gland organoids containing PSCs, salivary gland cells and, magnetic nanoparticles modified iPSCs.
(B) Matrigel, 3D microwell, and elastin-loaded PLGA nanofibers are needed to structure salivary gland organoids. Moreover, instead of the utilization of scaffolds, a 3D bioprinting platform is also able to organize magnetic nanoparticle-modified PSCs to form specific morphology of organoids.
(C) In culture systems, different growth factors are of necessity for cell self-organization to form organoids.
(D) Salivary gland organoids can be generated by seeding the stem cells onto scaffold with the supplement of appropriate growth factors. iPSCs, induced pluripotent stem cells; PLGA, poly (lactic-co-glycolic acid).
In the former study, entire 3D salivary gland organoids were successfully structured in vitro by seeding human salivary gland cells in the Matrigel scaffold.107 Besides, Tanaka et al. found the indispensable role of sex-determining region Y box 9 (Sox9) and forkhead box protein C1 (Foxc1) in the formation of salivary gland organoids. The PSCs were seeded into Matrigel and incubated with various molecules including BMP4 and FGF2 to differentiate into oral ectoderm. Subsequently, after the infection of recombinant adenovirus encoding Sox9 and Foxc1, the outer layer of the oral ectoderm was further cultured with FGF10 and FGF7 to develop into salivary gland organoids.13 After transplantation in mice, the induced salivary gland organoids exhibited not only similar morphology and gene expression with normal organs, but also possessed the saliva secretion ability. Nevertheless, the nonhuman-derived scaffolds limited the clinical application to repair and regenerate salivary glands in humans. Hence, these scaffolds could only be applied to study the protein expression pattern of the salivary glands.74
Alternatively, complex hydrogel scaffolds have been created for the generation of salivary gland organoids for clinical application. The bio-engineered salivary gland organoids were developed by a niche-independent method with the guidance of PEG hydrogel-incorporated PCL nanofibrous microwell scaffolds.108 The generation process involved two steps: priming and differentiation. After seeding on the scaffolds and forming aggregation, single clonal salivary gland stem cells further differentiated to generate salivary gland organoids, whereas the size of the 3D structure is relatively limited. Moreover, membrane protein-combined hydrogels also raise much more attention. Elastin, as an ECM protein beneficial for cell adhesion and stem cell differentiation, was modified with PLGA nanofibers via electrospinning.109 The hybrid scaffolds could advance the nanofibers in elasticity, wettability, and chemical nature and mimic the niches giving rise to better epithelial cell line self-organization. However, prior to clinical application, several studies have reported immunogenicity and tumorigenesis concerns about these protein-fabricated hybrid hydrogels as scaffolds to form salivary gland organoids.110,111 Besides, the byproducts generated by degrading these scaffolds could alter the pH and increase the temperature of niche, which could have serious adverse effects on the body.112
To overcome this shortcoming, a scaffold-free strategy is developed to culture the salivary gland organoids by the modification of the cell surface. Cell-based bioprinting has emerged as a promising platform to generate salivary gland organoids. Adine et al. fabricated a magnetic 3D bioprinting platform to spatially control the self-organization and formed bio-engineered innervated salivary gland organoids with bio-functional secretory epithelia.113 The surface membrane of human dental pulp stem cells (hDPSCs) was tagged with magnetic nanoparticles and subsequently seeded in 96-well plates to form cell aggregation. After the incubation with FGF10, the 3D spheroids grew into 3D salivary gland organoids with better neuronal compartments and excellent secretory function; however, these salivary gland organoids had limited vascularization. The same method was also applied in studying the role of exosomes derived from salivary gland organoids. The salivary gland organoids were developed by stable magnetic 3D bioprinting platforms, which provided a promising alternative to repair and regenerate the damaged salivary gland.114
Besides, glandular diversity and heterogeneous cell types would be successfully maintained in developed salivary gland organoids via modulating culture niches. Yoon et al. reported that compared to conventional culture components such as EGF and WNT signals, neuregulin 1 had the capacity to promote stem cell differentiation and avoid single-cell dissociation. This culture component could effectively develop organoids with stable and recapitulative cell diversity as opposed to generating excessive keratinized core.115 The advanced research for alternative components of the microenvironments may be promising in generating cell-type-specific organoids for salivary gland regeneration.
Despite the advancement in bioengineering salivary gland organoids, the vascularization of salivary gland organoids and the identification of essential and crucial signals for the successful generation of organoids are a few concerns that should be addressed. Therefore, in order to repair and regenerate damaged salivary glands for clinical application, future studies are supposed to concentrate on optimizing the size and function of organoids.
Oral cancer organoids
Oral cancer has been the sixth most malignant cancer worldwide due to the rising incidence, severity and prognosis.116 Mainstream therapy of oral cancer mainly contains surgery, radiotherapy, and chemotherapy, which may fail to completely treat refractory oral cancer due to relatively limited research on oral cancer mechanisms. However, oral cancer organoids, which mimic in vivo tumor microenvironments, have been developed, which could be used to study the underlying mechanism of tumorigenesis. This could provide a suitable platform for developing therapeutic strategies, specifically personalized treatment.
Tanaka et al. successfully generated head and neck cancer organoids by modifying protocols to generate tumor-derived spheroids. The tissues of patients with cancers were cultured in DMEM and transferred to Matrigel supplemented with bFGF to generate 3D spheroids. Versus the original tumor, head and neck cancer organoids possessed similar biochemical and biophysical characteristics, particularly the tumor protein p53 mutational status.13 Further, cancer stem cells harvested from patients and cultured in Matrigel could generate oral cancer organoids, which exhibit histopathology and cellular heterogeneity of the tumor sample. However, cancer stem cell properties such as enrichment and expansion may be hard to maintain in vitro. In order to solve the present problem and prolong the lifespan of cancer organoids, Zhao et al. bioengineered the niches of organoids by co-culturing cancer-associated fibroblast with oral cancer organoids to explore the function of fibroblast in tumorigenesis.14 Results demonstrated that the co-culture of cancer-associated fibroblast with organoids successfully promoted stem cell properties and improved the organoids-forming ability by secreting lactate.
Although there are few advantages of using conventional methods to generate oral cancer organoids, several methods have been developed to bioengineer oral cancer organoids by simulating in vivo tumor microenvironments. Decellularized tongue extracellular matrix is fabricated as a scaffold to form tongue squamous cell carcinoma (TSCC) organoids by seeding TSCC cells.117 After decellularization, ECM still retained components such as laminin and collagen, which simulates the TSCC microenvironment and promote the formation of TSCC organoids, retaining the migratory and invasive properties of the original cells. Moreover, Noi et al. fabricated a non-woven silica fiber sheet as a novel scaffold to support human oral squamous cell-3 cells for the generation of oral cancer organoids.118 The silica fiber scaffold structure was similar to the loose connective tissue structure in vivo, which would not inhibit cell growth and migration. Compared with animal-derived Matrigel, silica fiber scaffold is easy to be modified.
The present progress achieved in oral cancer organoids development is still inadequate. The inability of current oral cancer organoids to precisely recapitulate the tumor microenvironment still plagues the application in personalized cancer therapy and drug screening. More advanced methods to engineer organoids deserve to be studied in the future.
Taste bud organoids
Taste buds, as effective taste receptors existing in fungiform, foliate, and circumvallate papillae, are important for maintaining the quality of life. Taste bud organoids are able to explore the underlying mechanism of taste function and contribute to taste bud regeneration in vitro. Leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) cells are ASCs in posterior tongue. Ren et al. seeded Lgr5+ cells on the Matrigel to generate taste bud organoids with mature taste receptor cells.119
However, taste bud organoids constructed by conventional methods are unable to form accessible localization of taste receptor cells. These cells are enclosed inside the organoid and play an imperative role in evaluating taste response via the application of calcium imaging. So, Adpaikar et al. utilized a suspension combined Matrigel method to culture taste bud organoids, which could recapitulate the taste epithelium homeostasis.120 The epithelium of circumvallate and foliate papillae-derived cell pellets were cultured in DMEM/F12 medium with the supplement of various epidermal growth factors and guidance of Matrigel as a scaffold. After 4 days of culture, 3D spherical structure was re-suspended in a culture medium without Matrigel to develop into engineered taste bud organoids. An increased number of stem cells and taste receptor cells were observed in the newly developed taste bud organoids and can benefit regenerative medicine. Besides, Lee et al. used decellularized tongue matrix as scaffolds on microfluidic devices to fabricate an artificial tongue device, which could efficiently mimic in vivo taste bud microenvironment and serve as an efficient and sensitive taste sensor system.121 After seeding appropriate stem cells, the developed device could be used to generate taste bud organoids similar to taste buds in vivo. The advantage of this device was to yield stable substance exchange and apply decellularized tongue-derived matrix promoting cell adhesion and providing growth factors necessary for organogenesis. More efficient and functional sensors for taste detection may also be realized by the microfluidic system via dynamically analyzing signal transmission. Even though taste bud organoids have not been generated by this method yet, this device indeed constructs a strategy for precisely mimicking niches in vivo and applicating in taste tissue regeneration.
Overall, current methods to generate advanced taste bud organoids with increased taste receptor cells still lack more sensitive taste sensor platforms to verify the effectiveness of taste sensors of organoids compared with their in vivo counterparts. Therefore, in order to achieve clinical taste bud regeneration, microfluidic devices, which can provide a more stable system to standardly monitor the taste sensation of taste bud organoids, are supposed to be applied in the development of taste bud organoids.
Lingual epithelial organoids
Due to the epidemic of tongue cancer around the world, researchers studying the mechanism of lingual epithelial renewal and regeneration through organoids draw more and more attention. Hisha et al. generated lingual epithelial organoids using B cell-specific Moloney murine leukemia virus insertion site 1 positive lingual epithelial cells, which were seeded in Matrigel and supplemented with growth factors such as EGF, noggin, and R-spondin1. These organoids were round in shape and had concentric cell arrangement.122 After transplantation, the grafted organoids grew and maturated in the muscular layer of the tongue instead of only in the epithelial layer, indicating the potential application in lingual regeneration. However, the limitation of this method is the difficulty of organoids to form specific morphology even though culture conditions are identical. This may attribute to insufficient culture components to mimic niches in vivo and uncontrollable self-organization to generate organoids with similar shapes and sizes.
Although current lingual epithelial organoids have repaired tongues in the muscular layer rather than only in the epithelial layer, there is an urgent need to develop innovative approaches to bio-engineer organoids. Studies should focus on controlling the self-organization of stem cells in organoids by evaluating complex niches and using shape-controlled devices to develop fully functional lingual epithelial organoids with morphology similar to actual organs for clinical regeneration.
Maxillofacial cartilage organoids
Maxillofacial cartilage is comprised of hyaline cartilage of the nose, developing bones of the head, and fibrocartilage of temporomandibular joints. In order to generate hyaline cartilage organoids, Crispim et al. used spinner flasks to culture bovine chondrocytes with the supplement of notochordal cell-derived matrix, which was a decellularized biologic matrix similar to cartilage in composition.17 Subsequently, the newly developed hyaline cartilage organoids were encapsulated in hydrogel alginate with suitable elastic property which could enhance the proliferation of cells and simultaneously sustain the expression of sex-determining region Y-box 9, indicating the excellent chondrocytes activity after in vitro culture for 24 days. This research guaranteed the mass production of cartilage organoids with appropriate chondrocyte activity, showing the potential for large-scale cartilage regeneration. However, whether this method is suitable for human cartilage regeneration requires to be verified by using human chondrocytes to construct cartilage organoids.
Currently, even though advanced cartilage organoids with superior chondrogenic activity and potential for mass production, the clinical application of organoids for maxillofacial cartilage regeneration still faces challenges including source-limited human embryonic stem cells and xenogeneic immune rejection. Therefore, more research should be encouraged to employ PSCs and ASCs derived from humans as cell sources in developing maxillofacial cartilage organoids before clinical therapy.
Limitations of current oral and maxillofacial organoids design and prospects
Although oral and maxillofacial organoids have been successfully used for tissue regeneration in past decades, functional and morphological differences exist in organoids formed in vitro and actual organs. Embryonic stem cells are widely used to develop mature organoids; however, their source is limited and has ethical concerns, thereby restricting their clinical application.
Apart from the source of cells, there is still uncertainty regarding the underlying mechanisms of organogenesis and components required for culturing the organoids, which play an important role in regulating the self-organization of stem cells. These factors pose a major challenge in organoid culturing and development. As an alternative to embryonic stem cells, PSCs are utilized in generating various organoids. However, PSCs have diverse differentiation potential, resulting in immature organoid formation. It is difficult to precisely control the self-organizing ability of PSCs in vitro unless the cells are cultured in optimized conditions in the presence of supporting niche and suitable growth factors, which can effectively mimic in vivo microenvironment. Therefore, different technologies for developing organoids by simulating the chemical and physical characteristics of the culture microenvironment and allowing spatiotemporal modulation of bioactive factors become an emerging strategy. Tremendous advancements have been made in modifying intestinal123 and neural124 organoids by bioengineering organoids. However, only a few studies have focused on improving the functions and morphology of oral and maxillofacial organoids. Thus, considering various methods to engineer other organoids and specific properties of oral and maxillofacial organoids, several feasible approaches deserving to be implemented for improving oral and maxillofacial organoids are listed as follows.
Most current methods to modify oral and maxillofacial organoids rely on simulating the stiffness and architecture of ECM through 3D bioprinting and novel biomaterials as scaffolds. However, precise spatiotemporal regulation and control of self-organization need to be attained by utilizing microfluidic devices and further engineered scaffolds. For instance, multiple growth factors facilitating stem cell differentiation can be spatially immobilized in modified hydrogels.83 The scaffolds developed using photochemistry could be used to promote hydrogel degradation on light stimulation in a time-dependent manner. This fabricated scaffold could mimic the degradation of the enamel matrix for regulating the architecture of tooth germ organoids for tooth regeneration.125 Besides, the stable and sufficient cues provided by microfluidic devices can mimic in vivo microenvironment, which can control the self-organizing ability of organoids for the long term and prolong their lifespan of the organoids. In addition to mimicking the in vivo microenvironment, the intricated microfluidic devices can also simulate the interaction between various organs by culturing different organoids. This would aid in understanding the influence of multi-organ diseases on the functions and morphology of oral organoids, which would be impossible to study using single organoids.126 Moreover, using microfluidic systems to high-throughput screening and detection niches provides a cost-effective platform to explore the most optimized niches of oral organoids and enables the study of organoids development and clinical applications.121
Further, more sophisticated oral organoids can be generated via gene editing. The utilization of CRISPR-Cas9 technology can further elucidate the mechanism of organogenesis and disease progression to alleviate the limited understanding of oral and maxillofacial systems. After acquiring complex knowledge of the signal pathway of organogenesis, genes contributing to oral and maxillofacial organoids generation may be knocked in via genome editing.127 This technology is able to effectively elevate the expression of various signal pathways thereby forming mature organoids. Besides, with the combination of gene editing, optogenetic technology may also become another effective approach to precisely regulate the self-organization of stem cells in a spatiotemporal manner.128 It was reported that optogenetics combined with CRISPR-Cas9 could precisely control the activation of WNT/β-catenin signal pathway in PSCs thereby triggering transcriptional changes and mesoderm differentiation of PSCs.129 This research indicates that optogenetics may also be a promising tool for regulating various signal pathways to spatiotemporally control the fate of stem cells for designing oral and maxillofacial organoids.
The above-mentioned approaches may guide the progression of oral organoids in the future by controlling microenvironment components as well as reprogramming genomes to manipulate the self-organization of cells. The construction of engineered oral and maxillofacial organoids is gaining momentum, which is bound to prosper regeneration and development of oral and maxillofacial systems and achieve more breakthroughs in the global healthcare and dental field.
Conclusion
Oral and maxillofacial organoids break through the bottleneck of conventional 2D culture since they effectively recapitulate the architecture and function of tissues and cells in vitro. These characteristics enable them to be widely applied in tissue regeneration and disease treatment. To overcome the shortcomings of the construction of oral and maxillofacial organoids, various advanced methods to engineer oral and maxillofacial organoids make it possible to generate organoids that are similar in structures and functions to their in vivo counterparts. Various approaches to engineering organoids have been represented, through which structure and function similar to the actual organs could be promised for organoids produced in vitro. Currently, various methods, such as 3D bioprinting and fabricated polymer scaffolds, can effectively mimick niches in vivo for organoid construction. However, challenge especially in precisely regulating the self-organization of organoids still exist. More efforts in a multidisciplinary manner to further bioengineer oral and maxillofacial organoids are required for oral and maxillofacial regeneration.
Acknowledgments
We sincerely thank Dr. Baoxin Tao from Shanghai Ninth People’ Hospital for the generous assistance to revise the article and Dr. Manlin Qi from the Hospital of Stomatology Affiliated with Jilin University for the generous help with the revised figures. This work was supported by the National Key R&D Program of China (2022YFA1103200), Shanghai Academic Leader of Science and Technology Innovation Action Plan (20XD1424000), Shanghai Experimental Animal Research Project of Science and Technology Innovation Action Plan (201409006400), and National Natural Science Foundation of China (82061130222, 82270963) awarded to Yao Sun.
Author contributions
Yu Wang contributed to the conception, design, and drafted the article. Yao Sun contributed to the conception and design and critically revised the article. All authors gave final approval and agree to be accountable for all aspects of the work.
Declaration of interests
The authors declare that they have no competing interests.
References
- 1.Liu G., Guo Y., Zhang L., Wang X., Liu R., Huang P., Xiao Y., Chen Z., Chen Z. A standardized rat burr hole defect model to study maxillofacial bone regeneration. Acta Biomater. 2019;86:450–464. doi: 10.1016/j.actbio.2018.12.049. [DOI] [PubMed] [Google Scholar]
- 2.Robb G.L., Marunick M.T., Martin J.W., Zlotolow I.M. Midface reconstruction: surgical reconstruction versus prosthesis. Head Neck. 2001;23:48–58. doi: 10.1002/1097-0347(200101)23:1<48::AID-HED8>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
- 3.Chen Q., Abasi K., Gong Z., Ling B., Liu H., Shao B. Inferiorly pedicled nasolabial flap for reconstruction of anterior maxilla defects class I and II. J. Craniofac. Surg. 2018;29:457–459. doi: 10.1097/scs.0000000000004203. [DOI] [PubMed] [Google Scholar]
- 4.Chen X., Bai S., Li B., Liu H., Wu G., Liu S., Zhao Y. Fabrication of gelatin methacrylate/nanohydroxyapatite microgel arrays for periodontal tissue regeneration. Int. J. Nanomed. 2016;11:4707–4718. doi: 10.2147/ijn.S111701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fatehullah A., Tan S.H., Barker N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 2016;18:246–254. doi: 10.1038/ncb3312. [DOI] [PubMed] [Google Scholar]
- 6.Rossi G., Manfrin A., Lutolf M.P. Progress and potential in organoid research. Nat. Rev. Genet. 2018;19:671–687. doi: 10.1038/s41576-018-0051-9. [DOI] [PubMed] [Google Scholar]
- 7.Yin X., Mead B.E., Safaee H., Langer R., Karp J.M., Levy O. Engineering stem cell organoids. Cell Stem Cell. 2016;18:25–38. doi: 10.1016/j.stem.2015.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lancaster M.A., Knoblich J.A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125. doi: 10.1126/science.1247125. [DOI] [PubMed] [Google Scholar]
- 9.Zhang D.Y., Song H., Ming G.L. Modeling neurological disorders using brain organoids. Semin. Cell Dev. Biol. 2021;111:4–14. doi: 10.1016/j.semcdb.2020.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dotti I., Salas A. Potential use of human stem cell-derived intestinal organoids to study inflammatory bowel diseases. Inflamm. Bowel Dis. 2018;24:2501–2509. doi: 10.1093/ibd/izy275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Schwank G., Koo B.K., Sasselli V., Dekkers J.F., Heo I., Demircan T., Sasaki N., Boymans S., Cuppen E., van der Ent C.K., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell. 2013;13:653–658. doi: 10.1016/j.stem.2013.11.002. [DOI] [PubMed] [Google Scholar]
- 12.Zhang W., Vazquez B., Oreadi D., Yelick P.C. Decellularized tooth bud scaffolds for tooth regeneration. J. Dent. Res. 2017;96:516–523. doi: 10.1177/0022034516689082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tanaka N., Osman A.A., Takahashi Y., Lindemann A., Patel A.A., Zhao M., Takahashi H., Myers J.N. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncol. 2018;87:49–57. doi: 10.1016/j.oraloncology.2018.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhao H., Jiang E., Shang Z. 3D co-culture of cancer-associated fibroblast with oral cancer organoids. J. Dent. Res. 2021;100:201–208. doi: 10.1177/0022034520956614. [DOI] [PubMed] [Google Scholar]
- 15.Liu S., Zhu P., Tian Y., Chen Y., Liu Y., Chen W., Du L., Wu C. Preparation and application of taste bud organoids in biomedicine towards chemical sensation mechanisms. Biotechnol. Bioeng. 2022;119:2015–2030. doi: 10.1002/bit.28109. [DOI] [PubMed] [Google Scholar]
- 16.Hisha H., Ueno H. Organoid culture of lingual epithelial cells in a three-dimensional matrix. Methods Mol. Biol. 2019;1576:93–99. doi: 10.1007/7651_2016_3. [DOI] [PubMed] [Google Scholar]
- 17.Crispim J.F., Ito K. De novo neo-hyaline-cartilage from bovine organoids in viscoelastic hydrogels. Acta Biomater. 2021;128:236–249. doi: 10.1016/j.actbio.2021.04.008. [DOI] [PubMed] [Google Scholar]
- 18.Li L., Xie T. Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 2005;21:605–631. doi: 10.1146/annurev.cellbio.21.012704.131525. [DOI] [PubMed] [Google Scholar]
- 19.Driehuis E., Kolders S., Spelier S., Lõhmussaar K., Willems S.M., Devriese L.A., de Bree R., de Ruiter E.J., Korving J., Begthel H., et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 2019;9:852–871. doi: 10.1158/2159-8290.Cd-18-1522. [DOI] [PubMed] [Google Scholar]
- 20.Nakao K., Morita R., Saji Y., Ishida K., Tomita Y., Ogawa M., Saitoh M., Tomooka Y., Tsuji T. The development of a bioengineered organ germ method. Nat. Methods. 2007;4:227–230. doi: 10.1038/nmeth1012. [DOI] [PubMed] [Google Scholar]
- 21.Koslow M., O'Keefe K.J., Hosseini Z.F., Nelson D.A., Larsen M. ROCK inhibitor increases proacinar cells in adult salivary gland organoids. Stem Cell Res. 2019;41:101608. doi: 10.1016/j.scr.2019.101608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Randriamanantsoa S., Papargyriou A., Maurer H.C., Peschke K., Schuster M., Zecchin G., Steiger K., Öllinger R., Saur D., Scheel C., et al. Spatiotemporal dynamics of self-organized branching in pancreas-derived organoids. Nat. Commun. 2022;13:5219. doi: 10.1038/s41467-022-32806-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Roper J., Tammela T., Akkad A., Almeqdadi M., Santos S.B., Jacks T., Yilmaz Ö.H. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Nat. Protoc. 2018;13:217–234. doi: 10.1038/nprot.2017.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sun Y., Ding Q. Genome engineering of stem cell organoids for disease modeling. Protein Cell. 2017;8:315–327. doi: 10.1007/s13238-016-0368-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Teriyapirom I., Batista-Rocha A.S., Koo B.K. Genetic engineering in organoids. J. Mol. Med. 2021;99:555–568. doi: 10.1007/s00109-020-02029-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cho A.N., Jin Y., An Y., Kim J., Choi Y.S., Lee J.S., Kim J., Choi W.Y., Koo D.J., Yu W., et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat. Commun. 2021;12:4730. doi: 10.1038/s41467-021-24775-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Heo J.H., Kang D., Seo S.J., Jin Y. Engineering the extracellular matrix for organoid culture. Int. J. Stem Cells. 2022;15:60–69. doi: 10.15283/ijsc21190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lee H.J., Mun S., Pham D.M., Kim P. Extracellular matrix-based hydrogels to tailoring tumor organoids. ACS Biomater. Sci. Eng. 2021;7:4128–4135. doi: 10.1021/acsbiomaterials.0c01801. [DOI] [PubMed] [Google Scholar]
- 29.Abdollahi S. Extracellular vesicles from organoids and 3D culture systems. Biotechnol. Bioeng. 2021;118:1029–1049. doi: 10.1002/bit.27606. [DOI] [PubMed] [Google Scholar]
- 30.Oksdath M., Perrin S.L., Bardy C., Hilder E.F., DeForest C.A., Arrua R.D., Gomez G.A. Review: synthetic scaffolds to control the biochemical, mechanical, and geometrical environment of stem cell-derived brain organoids. APL Bioeng. 2018;2:041501. doi: 10.1063/1.5045124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wu D.T., Munguia-Lopez J.G., Cho Y.W., Ma X., Song V., Zhu Z., Tran S.D. Polymeric scaffolds for dental, oral, and craniofacial regenerative medicine. Molecules. 2021;26:7043. doi: 10.3390/molecules26227043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Low J.H., Li P., Chew E.G.Y., Zhou B., Suzuki K., Zhang T., Lian M.M., Liu M., Aizawa E., Rodriguez Esteban C., et al. Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network. Cell Stem Cell. 2019;25:373–387.e9. doi: 10.1016/j.stem.2019.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Fujii M., Sato T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat. Mater. 2021;20:156–169. doi: 10.1038/s41563-020-0754-0. [DOI] [PubMed] [Google Scholar]
- 34.Lei M., Schumacher L.J., Lai Y.C., Juan W.T., Yeh C.Y., Wu P., Jiang T.X., Baker R.E., Widelitz R.B., Yang L., Chuong C.M. Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells. Proc. Natl. Acad. Sci. USA. 2017;114:E7101–E7110. doi: 10.1073/pnas.1700475114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Henon P.R. Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering. Adv. Exp. Med. Biol. 2003;534:27–45. doi: 10.1007/978-1-4615-0063-6_3. [DOI] [PubMed] [Google Scholar]
- 36.Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586–1597. doi: 10.1016/j.cell.2016.05.082. [DOI] [PubMed] [Google Scholar]
- 37.Sharpe P.T. Dental mesenchymal stem cells. Development. 2016;143:2273–2280. doi: 10.1242/dev.134189. [DOI] [PubMed] [Google Scholar]
- 38.McCracken K.W., Catá E.M., Crawford C.M., Sinagoga K.L., Schumacher M., Rockich B.E., Tsai Y.H., Mayhew C.N., Spence J.R., Zavros Y., Wells J.M. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014;516:400–404. doi: 10.1038/nature13863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Xinaris C., Brizi V., Remuzzi G. Organoid models and applications in biomedical research. Nephron. 2015;130:191–199. doi: 10.1159/000433566. [DOI] [PubMed] [Google Scholar]
- 40.Kim E.J., Yoon K.S., Arakaki M., Otsu K., Fukumoto S., Harada H., Green D.W., Lee J.M., Jung H.S. Effective differentiation of induced pluripotent stem cells into dental cells. Dev. Dynam. 2019;248:129–139. doi: 10.1002/dvdy.24663. [DOI] [PubMed] [Google Scholar]
- 41.Xu R., Boreland A.J., Li X., Erickson C., Jin M., Atkins C., Pang Z.P., Daniels B.P., Jiang P. Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. Stem Cell Rep. 2021;16:1923–1937. doi: 10.1016/j.stemcr.2021.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Messina A., Luce E., Hussein M., Dubart-Kupperschmitt A. Pluripotent-stem-cell-derived hepatic cells: hepatocytes and organoids for liver therapy and regeneration. Cells. 2020;9:420. doi: 10.3390/cells9020420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sasai Y. Cytosystems dynamics in self-organization of tissue architecture. Nature. 2013;493:318–326. doi: 10.1038/nature11859. [DOI] [PubMed] [Google Scholar]
- 44.Wang D., Guo Y., Zhu J., Liu F., Xue Y., Huang Y., Zhu B., Wu D., Pan H., Gong T., et al. Hyaluronic acid methacrylate/pancreatic extracellular matrix as a potential 3D printing bioink for constructing islet organoids. Acta Biomater. 2022 doi: 10.1016/j.actbio.2022.06.036. [DOI] [PubMed] [Google Scholar]
- 45.Pampaloni F., Stelzer E. Three-dimensional cell cultures in toxicology. Biotechnol. Genet. Eng. Rev. 2010;26:117–138. doi: 10.5661/bger-26-117. [DOI] [PubMed] [Google Scholar]
- 46.Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265. doi: 10.1038/nature07935. [DOI] [PubMed] [Google Scholar]
- 47.Gao Z., Wu T., Xu J., Liu G., Xie Y., Zhang C., Wang J., Wang S. Generation of bioartificial salivary gland using whole-organ decellularized bioscaffold. Cells Tissues Organs. 2014;200:171–180. doi: 10.1159/000371873. [DOI] [PubMed] [Google Scholar]
- 48.Nicoletti A., Fiorini M., Paolillo J., Dolcini L., Sandri M., Pressato D. Effects of different crosslinking conditions on the chemical-physical properties of a novel bio-inspired composite scaffold stabilised with 1, 4-butanediol diglycidyl ether (BDDGE) J. Mater. Sci. Mater. Med. 2013;24:17–35. doi: 10.1007/s10856-012-4782-4. [DOI] [PubMed] [Google Scholar]
- 49.Liu H., Wang Y., Cui K., Guo Y., Zhang X., Qin J. Advances in hydrogels in organoids and organs-on-a-chip. Adv. Mater. 2019;31:e1902042. doi: 10.1002/adma.201902042. [DOI] [PubMed] [Google Scholar]
- 50.Takasato M., Er P.X., Becroft M., Vanslambrouck J.M., Stanley E.G., Elefanty A.G., Little M.H. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 2014;16:118–126. doi: 10.1038/ncb2894. [DOI] [PubMed] [Google Scholar]
- 51.Eiraku M., Watanabe K., Matsuo-Takasaki M., Kawada M., Yonemura S., Matsumura M., Wataya T., Nishiyama A., Muguruma K., Sasai Y. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell. 2008;3:519–532. doi: 10.1016/j.stem.2008.09.002. [DOI] [PubMed] [Google Scholar]
- 52.Muguruma K., Nishiyama A., Kawakami H., Hashimoto K., Sasai Y. Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep. 2015;10:537–550. doi: 10.1016/j.celrep.2014.12.051. [DOI] [PubMed] [Google Scholar]
- 53.Eiraku M., Takata N., Ishibashi H., Kawada M., Sakakura E., Okuda S., Sekiguchi K., Adachi T., Sasai Y. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472:51–56. doi: 10.1038/nature09941. [DOI] [PubMed] [Google Scholar]
- 54.Tanaka J., Ogawa M., Hojo H., Kawashima Y., Mabuchi Y., Hata K., Nakamura S., Yasuhara R., Takamatsu K., Irié T., et al. Generation of orthotopically functional salivary gland from embryonic stem cells. Nat. Commun. 2018;9:4216. doi: 10.1038/s41467-018-06469-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hosseini Z.F., Nelson D.A., Moskwa N., Sfakis L.M., Castracane J., Larsen M. FGF2-dependent mesenchyme and laminin-111 are niche factors in salivary gland organoids. J. Cell Sci. 2018;131:jcs208728. doi: 10.1242/jcs.208728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Lewis A., Keshara R., Kim Y.H., Grapin-Botton A. Self-organization of organoids from endoderm-derived cells. J. Mol. Med. 2021;99:449–462. doi: 10.1007/s00109-020-02010-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Amaral A.J.R., Pasparakis G. Cell membrane engineering with synthetic materials: applications in cell spheroids, cellular glues and microtissue formation. Acta Biomater. 2019;90:21–36. doi: 10.1016/j.actbio.2019.04.013. [DOI] [PubMed] [Google Scholar]
- 58.Krishnamurthy S., Muthukumaran P., Jayakumar M.K.G., Lisse D., Masurkar N.D., Xu C., Chan J.M., Drum C.L. Surface protein engineering increases the circulation time of a cell membrane-based nanotherapeutic. Nanomedicine. 2019;18:169–178. doi: 10.1016/j.nano.2019.02.024. [DOI] [PubMed] [Google Scholar]
- 59.Cheng H., Byrska-Bishop M., Zhang C.T., Kastrup C.J., Hwang N.S., Tai A.K., Lee W.W., Xu X., Nahrendorf M., Langer R., Anderson D.G. Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials. 2012;33:5004–5012. doi: 10.1016/j.biomaterials.2012.03.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Stephan M.T., Irvine D.J. Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials. Nano Today. 2011;6:309–325. doi: 10.1016/j.nantod.2011.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Rogozhnikov D., O'Brien P.J., Elahipanah S., Yousaf M.N. Scaffold free bio-orthogonal assembly of 3-dimensional cardiac tissue via cell surface engineering. Sci. Rep. 2016;6:39806. doi: 10.1038/srep39806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Fayol D., Frasca G., Le Visage C., Gazeau F., Luciani N., Wilhelm C. Use of magnetic forces to promote stem cell aggregation during differentiation, and cartilage tissue modeling. Adv. Mater. 2013;25:2611–2616. doi: 10.1002/adma.201300342. [DOI] [PubMed] [Google Scholar]
- 63.Akbari E., Mollica M.Y., Lucas C.R., Bushman S.M., Patton R.A., Shahhosseini M., Song J.W., Castro C.E. Engineering cell surface function with DNA origami. Adv. Mater. 2017;29 doi: 10.1002/adma.201703632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Nie J., Hashino E. Organoid technologies meet genome engineering. EMBO Rep. 2017;18:367–376. doi: 10.15252/embr.201643732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Velazquez J.J., LeGraw R., Moghadam F., Tan Y., Kilbourne J., Maggiore J.C., Hislop J., Liu S., Cats D., Chuva de Sousa Lopes S.M., et al. Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids. Cell Syst. 2021;12:41–55.e11. doi: 10.1016/j.cels.2020.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Deng W.L., Gao M.L., Lei X.L., Lv J.N., Zhao H., He K.W., Xia X.X., Li L.Y., Chen Y.C., Li Y.P., et al. Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Rep. 2018;10:1267–1281. doi: 10.1016/j.stemcr.2018.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Liu X., Cheng Y., Abraham J.M., Wang Z., Wang Z., Ke X., Yan R., Shin E.J., Ngamruengphong S., Khashab M.A., et al. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids. Cancer Lett. 2018;436:109–118. doi: 10.1016/j.canlet.2018.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Sthijns M.M.J.P.E., LaPointe V.L.S., van Blitterswijk C.A. Building complex life through self-organization. Tissue Eng. Part A. 2019;25:1341–1346. doi: 10.1089/ten.TEA.2019.0208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Hofer M., Lutolf M.P. Engineering organoids. Nat. Rev. Mater. 2021;6:402–420. doi: 10.1038/s41578-021-00279-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Kretzschmar K., Clevers H. Organoids: modeling development and the stem cell niche in a dish. Dev. Cell. 2016;38:590–600. doi: 10.1016/j.devcel.2016.08.014. [DOI] [PubMed] [Google Scholar]
- 71.Murrow L.M., Weber R.J., Gartner Z.J. Dissecting the stem cell niche with organoid models: an engineering-based approach. Development. 2017;144:998–1007. doi: 10.1242/dev.140905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Aisenbrey E.A., Murphy W.L. Synthetic alternatives to Matrigel. Nat. Rev. Mater. 2020;5:539–551. doi: 10.1038/s41578-020-0199-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Klotz B.J., Oosterhoff L.A., Utomo L., Lim K.S., Vallmajo-Martin Q., Clevers H., Woodfield T.B.F., Rosenberg A.J.W.P., Malda J., Ehrbar M., et al. A versatile biosynthetic hydrogel platform for engineering of tissue analogues. Adv. Healthc. Mater. 2019;8:e1900979. doi: 10.1002/adhm.201900979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Kozlowski M.T., Crook C.J., Ku H.T. Towards organoid culture without Matrigel. Commun. Biol. 2021;4:1387. doi: 10.1038/s42003-021-02910-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Davoudi Z., Peroutka-Bigus N., Bellaire B., Jergens A., Wannemuehler M., Wang Q. Gut organoid as a new platform to study alginate and chitosan mediated PLGA nanoparticles for drug delivery. Mar. Drugs. 2021;19:282. doi: 10.3390/md19050282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Vallmajo-Martin Q., Broguiere N., Millan C., Zenobi-Wong M., Ehrbar M. PEG/HA hybrid hydrogels for biologically and mechanically tailorable bone marrow organoids. Adv. Funct. Mater. 2020;30:1910282. doi: 10.1002/adfm.201910282. [DOI] [Google Scholar]
- 77.Heinemann S., Heinemann C., Wenisch S., Alt V., Worch H., Hanke T. Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model. Acta Biomater. 2013;9:4878–4888. doi: 10.1016/j.actbio.2012.10.010. [DOI] [PubMed] [Google Scholar]
- 78.Shi J., Yu X., Wang L., Liu Y., Gao J., Zhang J., Ma R., Liu R., Zhang Z. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. Biomaterials. 2013;34:9666–9677. doi: 10.1016/j.biomaterials.2013.08.049. [DOI] [PubMed] [Google Scholar]
- 79.Gjorevski N., Sachs N., Manfrin A., Giger S., Bragina M.E., Ordóñez-Morán P., Clevers H., Lutolf M.P. Designer matrices for intestinal stem cell and organoid culture. Nature. 2016;539:560–564. doi: 10.1038/nature20168. [DOI] [PubMed] [Google Scholar]
- 80.Broguiere N., Isenmann L., Hirt C., Ringel T., Placzek S., Cavalli E., Ringnalda F., Villiger L., Züllig R., Lehmann R., et al. Growth of epithelial organoids in a defined hydrogel. Adv. Mater. 2018;30:e1801621. doi: 10.1002/adma.201801621. [DOI] [PubMed] [Google Scholar]
- 81.Mammadov R., Mammadov B., Guler M.O., Tekinay A.B. Growth factor binding on heparin mimetic peptide nanofibers. Biomacromolecules. 2012;13:3311–3319. doi: 10.1021/bm3010897. [DOI] [PubMed] [Google Scholar]
- 82.Zieris A., Prokoph S., Levental K.R., Welzel P.B., Grimmer M., Freudenberg U., Werner C. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials. 2010;31:7985–7994. doi: 10.1016/j.biomaterials.2010.07.021. [DOI] [PubMed] [Google Scholar]
- 83.Wylie R.G., Ahsan S., Aizawa Y., Maxwell K.L., Morshead C.M., Shoichet M.S. Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels. Nat. Mater. 2011;10:799–806. doi: 10.1038/nmat3101. [DOI] [PubMed] [Google Scholar]
- 84.Zhou K., Yu P., Shi X., Ling T., Zeng W., Chen A., Yang W., Zhou Z. Hierarchically porous hydroxyapatite hybrid scaffold incorporated with reduced graphene oxide for rapid bone ingrowth and repair. ACS Nano. 2019;13:9595–9606. doi: 10.1021/acsnano.9b04723. [DOI] [PubMed] [Google Scholar]
- 85.Li H., Yin Y., Xiang Y., Liu H., Guo R. A novel 3D printing PCL/GelMA scaffold containing USPIO for MRI-guided bile duct repair. Biomed. Mater. 2020;15:045004. doi: 10.1088/1748-605X/ab797a. [DOI] [PubMed] [Google Scholar]
- 86.Nikolaev M., Mitrofanova O., Broguiere N., Geraldo S., Dutta D., Tabata Y., Elci B., Brandenberg N., Kolotuev I., Gjorevski N., et al. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis. Nature. 2020;585:574–578. doi: 10.1038/s41586-020-2724-8. [DOI] [PubMed] [Google Scholar]
- 87.Rossen N.S., Anandakumaran P.N., Zur Nieden R., Lo K., Luo W., Park C., Huyan C., Fu Q., Song Z., Singh-Moon R.P., et al. Injectable therapeutic organoids using sacrificial hydrogels. iScience. 2020;23:101052. doi: 10.1016/j.isci.2020.101052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Wörsdörfer P., Rockel A., Alt Y., Kern A., Ergün S. Generation of vascularized neural organoids by co-culturing with mesodermal progenitor cells. STAR Protoc. 2020;1:100041. doi: 10.1016/j.xpro.2020.100041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Lu D., Kassab G.S. Role of shear stress and stretch in vascular mechanobiology. J. R. Soc. Interface. 2011;8:1379–1385. doi: 10.1098/rsif.2011.0177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Homan K.A., Gupta N., Kroll K.T., Kolesky D.B., Skylar-Scott M., Miyoshi T., Mau D., Valerius M.T., Ferrante T., Bonventre J.V., et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat. Methods. 2019;16:255–262. doi: 10.1038/s41592-019-0325-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Mirabella T., MacArthur J.W., Cheng D., Ozaki C.K., Woo Y.J., Yang M., Chen C.S. 3D-printed vascular networks direct therapeutic angiogenesis in ischaemia. Nat. Biomed. Eng. 2017;1:0083. doi: 10.1038/s41551-017-0083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Chen M.B., Whisler J.A., Jeon J.S., Kamm R.D. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr. Biol. 2013;5:1262–1271. doi: 10.1039/c3ib40149a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Nashimoto Y., Hayashi T., Kunita I., Nakamasu A., Torisawa Y.S., Nakayama M., Takigawa-Imamura H., Kotera H., Nishiyama K., Miura T., Yokokawa R. Integrating perfusable vascular networks with a three-dimensional tissue in a microfluidic device. Integr. Biol. 2017;9:506–518. doi: 10.1039/c7ib00024c. [DOI] [PubMed] [Google Scholar]
- 94.Zhang Y.S., Aleman J., Shin S.R., Kilic T., Kim D., Mousavi Shaegh S.A., Massa S., Riahi R., Chae S., Hu N., et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc. Natl. Acad. Sci. USA. 2017;114:E2293–E2302. doi: 10.1073/pnas.1612906114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Pham M.T., Pollock K.M., Rose M.D., Cary W.A., Stewart H.R., Zhou P., Nolta J.A., Waldau B. Generation of human vascularized brain organoids. Neuroreport. 2018;29:588–593. doi: 10.1097/wnr.0000000000001014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Sequeira R.C., Criswell T., Atala A., Yoo J.J. Microfluidic systems for assisted reproductive technologies: advantages and potential applications. Tissue Eng. Regen. Med. 2020;17:787–800. doi: 10.1007/s13770-020-00311-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Jin Y., Kim J., Lee J.S., Min S., Kim S., Ahn D.H., Kim Y.G., Cho S.W. Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform. Adv. Funct. Mater. 2018;28:1801954. doi: 10.1002/adfm.201801954. [DOI] [Google Scholar]
- 98.Ono M., Oshima M., Ogawa M., Sonoyama W., Hara E.S., Oida Y., Shinkawa S., Nakajima R., Mine A., Hayano S., et al. Practical whole-tooth restoration utilizing autologous bioengineered tooth germ transplantation in a postnatal canine model. Sci. Rep. 2017;7:44522. doi: 10.1038/srep44522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Wang F., Wu Z., Fan Z., Wu T., Wang J., Zhang C., Wang S. The cell re-association-based whole-tooth regeneration strategies in large animal, Sus scrofa. Cell Prolif. 2018;51:e12479. doi: 10.1111/cpr.12479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.van Manen E.H.C., Zhang W., Walboomers X.F., Vazquez B., Yang F., Ji W., Yu N., Spear D.J., Jansen J.A., Yelick P.C. The influence of electrospun fibre scaffold orientation and nano-hydroxyapatite content on the development of tooth bud stem cells in vitro. Odontology. 2014;102:14–21. doi: 10.1007/s10266-012-0087-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Smith E.E., Yelick P.C. Bioengineering tooth bud constructs using GelMA hydrogel. Methods Mol. Biol. 2019;1922:139–150. doi: 10.1007/978-1-4939-9012-2_14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Smith E.E., Zhang W., Schiele N.R., Khademhosseini A., Kuo C.K., Yelick P.C. Developing a biomimetic tooth bud model. J. Tissue Eng. Regen. Med. 2017;11:3326–3336. doi: 10.1002/term.2246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Smith E.E., Angstadt S., Monteiro N., Zhang W., Khademhosseini A., Yelick P.C. Bioengineered tooth buds exhibit features of natural tooth buds. J. Dent. Res. 2018;97:1144–1151. doi: 10.1177/0022034518779075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Kilic Bektas C., Zhang W., Mao Y., Wu X., Kohn J., Yelick P.C. Self-assembled hydrogel microparticle-based tooth-germ organoids. Bioengineering. 2022;9:215. doi: 10.3390/bioengineering9050215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Eap S., Bécavin T., Keller L., Kökten T., Fioretti F., Weickert J.L., Deveaux E., Benkirane-Jessel N., Kuchler-Bopp S. Nanofibers implant functionalized by neural growth factor as a strategy to innervate a bioengineered tooth. Adv. Healthc. Mater. 2014;3:386–391. doi: 10.1002/adhm.201300281. [DOI] [PubMed] [Google Scholar]
- 106.Yoshimoto S., Yoshizumi J., Anzai H., Morishita K., Okamura K., Hiraki A., Hashimoto S. Inhibition of Alk signaling promotes the induction of human salivary-gland-derived organoids. Dis. Model. Mech. 2020;13:dmm045054. doi: 10.1242/dmm.045054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Maria O.M., Zeitouni A., Gologan O., Tran S.D. Matrigel improves functional properties of primary human salivary gland cells. Tissue engineering. Tissue Eng. Part A. 2011;17:1229–1238. doi: 10.1089/ten.TEA.2010.0297. [DOI] [PubMed] [Google Scholar]
- 108.Shin H.S., Hong H.J., Koh W.G., Lim J.Y. Organotypic 3D culture in nanoscaffold microwells supports salivary gland stem-cell-based organization. ACS Biomater. Sci. Eng. 2018;4:4311–4320. doi: 10.1021/acsbiomaterials.8b00894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Foraida Z.I., Kamaldinov T., Nelson D.A., Larsen M., Castracane J. Elastin-PLGA hybrid electrospun nanofiber scaffolds for salivary epithelial cell self-organization and polarization. Acta Biomater. 2017;62:116–127. doi: 10.1016/j.actbio.2017.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Delamarre E., Taboubi S., Mathieu S., Bérenguer C., Rigot V., Lissitzky J.C., Figarella-Branger D., Ouafik L., Luis J. Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells. Am. J. Pathol. 2009;175:844–855. doi: 10.2353/ajpath.2009.080920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Nam K., Maruyama C.L., Wang C.S., Trump B.G., Lei P., Andreadis S.T., Baker O.J. Laminin-111-derived peptide conjugated fibrin hydrogel restores salivary gland function. PLoS One. 2017;12:e0187069. doi: 10.1371/journal.pone.0187069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.da Silva D., Kaduri M., Poley M., Adir O., Krinsky N., Shainsky-Roitman J., Schroeder A. Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chem. Eng. J. 2018;340:9–14. doi: 10.1016/j.cej.2018.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Adine C., Ng K.K., Rungarunlert S., Souza G.R., Ferreira J.N. Engineering innervated secretory epithelial organoids by magnetic three-dimensional bioprinting for stimulating epithelial growth in salivary glands. Biomaterials. 2018;180:52–66. doi: 10.1016/j.biomaterials.2018.06.011. [DOI] [PubMed] [Google Scholar]
- 114.Chansaenroj A., Adine C., Charoenlappanit S., Roytrakul S., Sariya L., Osathanon T., Rungarunlert S., Urkasemsin G., Chaisuparat R., Yodmuang S., et al. Magnetic bioassembly platforms towards the generation of extracellular vesicles from human salivary gland functional organoids for epithelial repair. Bioact. Mater. 2022;18:151–163. doi: 10.1016/j.bioactmat.2022.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Yoon Y.J., Kim D., Tak K.Y., Hwang S., Kim J., Sim N.S., Cho J.M., Choi D., Ji Y., Hur J.K., et al. Salivary gland organoid culture maintains distinct glandular properties of murine and human major salivary glands. Nat. Commun. 2022;13:3291. doi: 10.1038/s41467-022-30934-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359–E386. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
- 117.Zhao L., Huang L., Yu S., Zheng J., Wang H., Zhang Y. Decellularized tongue tissue as an in vitro model for studying tongue cancer and tongue regeneration. Acta Biomater. 2017;58:122–135. doi: 10.1016/j.actbio.2017.05.062. [DOI] [PubMed] [Google Scholar]
- 118.Noi M., Mukaisho K.I., Yoshida S., Murakami S., Koshinuma S., Adachi T., Machida Y., Yamori M., Nakayama T., Yamamoto G., Sugihara H. ERK phosphorylation functions in invadopodia formation in tongue cancer cells in a novel silicate fibre-based 3D cell culture system. Int. J. Oral Sci. 2018;10:30. doi: 10.1038/s41368-018-0033-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Ren W., Lewandowski B.C., Watson J., Aihara E., Iwatsuki K., Bachmanov A.A., Margolskee R.F., Jiang P. Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo. Proc. Natl. Acad. Sci. USA. 2014;111:16401–16406. doi: 10.1073/pnas.1409064111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Adpaikar A.A., Zhang S., Kim H.Y., Kim K.W., Moon S.J., Lee J.M., Jung H.S. Fine-tuning of epithelial taste bud organoid to promote functional recapitulation of taste reactivity. Cell. Mol. Life Sci. 2022;79:211. doi: 10.1007/s00018-022-04242-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Lee J.S., Cho A.N., Jin Y., Kim J., Kim S., Cho S.W. Bio-artificial tongue with tongue extracellular matrix and primary taste cells. Biomaterials. 2018;151:24–37. doi: 10.1016/j.biomaterials.2017.10.019. [DOI] [PubMed] [Google Scholar]
- 122.Hisha H., Tanaka T., Kanno S., Tokuyama Y., Komai Y., Ohe S., Yanai H., Omachi T., Ueno H. Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells. Sci. Rep. 2013;3:3224. doi: 10.1038/srep03224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Kim G.A., Spence J.R., Takayama S. Bioengineering for intestinal organoid cultures. Curr. Opin. Biotechnol. 2017;47:51–58. doi: 10.1016/j.copbio.2017.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Fedorchak N.J., Iyer N., Ashton R.S. Bioengineering tissue morphogenesis and function in human neural organoids. Semin. Cell Dev. Biol. 2021;111:52–59. doi: 10.1016/j.semcdb.2020.05.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Yavitt F.M., Brown T.E., Hushka E.A., Brown M.E., Gjorevski N., Dempsey P.J., Lutolf M.P., Anseth K.S. The effect of thiol structure on allyl sulfide photodegradable hydrogels and their application as a degradable scaffold for organoid passaging. Adv. Mater. 2020;32:e1905366. doi: 10.1002/adma.201905366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Jalili-Firoozinezhad S., Miranda C.C., Cabral J.M.S. Modeling the human body on microfluidic chips. Trends Biotechnol. 2021;39:838–852. doi: 10.1016/j.tibtech.2021.01.004. [DOI] [PubMed] [Google Scholar]
- 127.Artegiani B., Hendriks D., Beumer J., Kok R., Zheng X., Joore I., Chuva de Sousa Lopes S., van Zon J., Tans S., Clevers H. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat. Cell Biol. 2020;22:321–331. doi: 10.1038/s41556-020-0472-5. [DOI] [PubMed] [Google Scholar]
- 128.Revah O., Gore F., Kelley K.W., Andersen J., Sakai N., Chen X., Li M.Y., Birey F., Yang X., Saw N.L., et al. Maturation and circuit integration of transplanted human cortical organoids. Nature. 2022;610:319–326. doi: 10.1038/s41586-022-05277-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Hellwarth P.B., Chang Y., Das A., Liang P., Lian X., Repina N.A., Bao X. Optogenetic-mediated cardiovascular differentiation and patterning of human pluripotent stem cells. Adv. Genet. 2021;2:e202100011. doi: 10.1002/ggn2.202100011. [DOI] [PMC free article] [PubMed] [Google Scholar]




